Abbott's Humira Approved for Ulcerative Colitis


Humira, Abbott's biggest seller, was recently approved by the FDA to treat ulcerative colitis.

Humira, Abbott’s biggest seller, was recently approved by the FDA to treat ulcerative colitis.

Patients with ulcerative colitis who have had an inadequate response to conventional therapy now have a new treatment option: Abbott’s Humira (adalimumab).

This approval marks the seventh indication for the blockbuster Humira. The drug was approved to treat ulcerative colitis after treatment with corticosteroids, azathioprine, and 6-mercaptopurine has failed. The drug was previously approved to treat rheumatoid arthritis (2002), psoriatic arthritis (2005), ankylosing spondylitis (2006), Crohn’s disease (2007), plaque psoriasis (2008), and juvenile idiopathic arthritis (2008).

Results from 2 studies encompassing 908 patients showed that 16.5% to 18.5% of patients treated with Humira achieved clinical remission compared with 9.2% to 9.3% of patients receiving placebo.

According to a Reuters report, the drug’s new indication could add $500 million dollars to Abbott’s revenue. The FDA’s approval makes it the first and only self-administered biologic treatment approved for use in this inflammatory bowel disease.

“There is significant unmet medical need in this patient population, which has not seen a new treatment approved in more than seven years,” said William Sandborn, division chief, gastroenterology, University of California, San Diego, in a press release. “This FDA approval is good news for patients and health care professionals who are seeking another option to manage the disease.”

Full prescribing information is available in this PDF.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
Capsules medicine and white medicine bottles on table | Image Credit: Satawat -
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn -
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl -
© 2024 MJH Life Sciences

All rights reserved.